ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less ...

July 4, 2024 — Researchers have discovered several rare types of helper T cells that are associated with immune disorders such as multiple sclerosis, rheumatoid arthritis, and even asthma.

These drugs are believed to work by trapping specific immune system cells in the lymph nodes, preventing them from entering the brain and spinal cord. Gilenya and Tascenso ODT are approved to treat ...

The medication works by tricking the immune cells into attacking it instead of the body's myelin ... including: According to the National Multiple Sclerosis Society, vertigo and dizziness are common ...

is extensively disrupted in immune cells isolated from untreated multiple sclerosis (MS) patients, and long-term treatment with interferon beta-based therapies largely corrects the defects ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Background: Multiple sclerosis is a chronic inflammatory disease ... in peripheral lymphocyte composition by decreasing CD4+ T cell percentage and increasing NK cells. In addition, PBMC production ...

Stationed within the meninges, squads of immune cells lie in wait, ready to unleash an inflammatory assault within the brain if needed. Holding these trigger-happy troops back during peacetime falls ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

Professors Christopher Goodnow and David Nemazee were honoured for their discovery of fundamental mechanisms that prevent B cells from attacking the body's own tissues in autoimmune diseases.

Jan. 31, 2025 — Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders -- T cells -- lose their ability to ...

MSCs regulate many effector functions of innate immune cells, such as antigen presentation by dendritic cells (DCs), natural killer (NK)-cell cytotoxicity and the activation of neutrophils.